Barclays
HNGE

Barclays’s Hinge Health HNGE Stock Holding History

Barclays’s Portfolio HNGE Stock Details HNGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.32M Buy
215,750
+44,562
+26% +$1.85M ﹤0.01% 1551
2025
Q4 		$7.95M Buy
171,188
+170,122
+15,959% +$8.19M ﹤0.01% 1867
2025
Q3 		$52.3K Buy
+1,066
New +$55.8K ﹤0.01% 4755

Other funds holding HNGE

IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $143M AUM
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Barclays's HNGE Position: Q1 2026 in Review

Barclays increased its Hinge Health (HNGE) stake by 26% in Q1 2026, buying an estimated $1.85M and bringing the position to 215,750 shares worth $8.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1551.

Barclays first reported a position in HNGE in Q3 2025 and has held it in 3 quarters since. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Barclays held 215,750 shares of Hinge Health worth $8.32M as of Q1 2026.
  • Barclays bought 44,562 Hinge Health shares in Q1 2026, an estimated $1.85M.
  • Hinge Health made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1551 holding.
  • Barclays first reported a position in Hinge Health in Q3 2025 and has held it in 3 quarters since.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.